Table 1.
Summary characteristics of included studies
Characteristics | No of trials (No of participants) |
---|---|
Eligible studies: | |
Total No of trials (No of participants) | 50 (74 655) |
Median (IQR) follow-up (years) | 1.0 (0.7-3.0) |
Follow-up at least three years | 12 (57 818) |
Median (IQR) No of participants | 251 (125-839) |
Total No of deaths | 7993 |
Median (IQR) % female | 64(40-100) |
Median (IQR) age (years) | 74 (65-80) |
Country: | |
European | 29 (32 840) |
American | 10 (31 240) |
Asian-Pacific | 10 (10 057) |
International country | 1 (518) |
Baseline 25 hydroxyvitamin D (nmol/L): | |
<25 | 4(886) |
25-50 | 21 (15 194) |
50-75 | 16 (24 408) |
>75 | 2 (26 058) |